03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Lacosamide Genepharm 100mg : | |
Type | Medicine Authorised |
Originator | Vimpat Tablets 100mg |
Agent | Nobel Pharm Plus |
Distributor | Nobel Pharm Plus |
Laboratory | Genepharm |
Responsible Party | Genepharm SA |
Origin | Greece |
Manufacturer | Genepharm SA |
Manufacturing Type | G |
Origin | Greece |
ATC | N03AX18 |
Lacosamide Genepharm 100mg :
Lacosamide Genepharm 100mg :
Lacosamide Genepharm 100mg :
Lacosamide Genepharm 100mg :
Lacosamide Genepharm 100mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Lacosamide Genepharm 100mg :
Lacosamide Genepharm 100mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Aggression | Uncommon |
Agitation | Uncommon |
Agranulocytosis | Not known |
ALT increased | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Uncommon |
Asthenia | Common |
Atrial fibrillation | Uncommon |
Atrial flutter | Uncommon |
Atrioventricular block (AVB) | Uncommon |
Balance disorder | Common |
Bradycardia | Uncommon |
Cognitive disorder | Common |
Confusional state | Common |
Constipation | Common |
Contusion | Common |
Coordination abnormal | Common |
Depression | Common |
Diarrhoea (Diarrhea) | Common |
Diplopia | Very Common |
Disturbance in attention | Common |
Dizziness | Very Common |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Not known |
Drug hypersensitivity | Uncommon |
Dry mouth (Xerostomia) | Common |
Dysarthria | Common |
Dyspepsia | Common |
ECG PR prolongation | Not known |
Euphoric mood | Uncommon |
Fall | Common |
Fatigue | Common |
Feeling drunk | Common |
Flatulence | Common |
Gait disturbance | Common |
Hallucination | Uncommon |
Headache | Very Common |
Hypoesthesia | Common |
Insomnia | Common |
Irritability | Common |
Laceration | Common |
Liver function test abnormal | Uncommon |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Memory impairment | Common |
Muscle spasms | Common |
Nausea | Very Common |
Nystagmus | Common |
Paraesthesia (paresthesia) | Common |
Pruritus | Common |
Psychotic disorders | Uncommon |
Pyrexia | Not known |
Skin rash | Common |
Somnolence | Common |
Stevens-Johnson syndrome | Not known |
Suicidal ideation | Uncommon |
Suicide attempt | Uncommon |
Syncope | Not known |
Tinnitus | Common |
Tremor | Common |
Urticaria | Uncommon |
Vertigo | Common |
Vision blurred | Common |
Vomiting | Common |
Lacosamide Genepharm 100mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Lacosamide Genepharm 100mg MoH 10849 :
Form | Tablet, Film-Coated |
Package Size | Box of 56 |
Strength | 100mg |
Public Price | 3156820.42 L.L. |
Stratum | B |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 156119/1 |
Submission date | 10/10/2019 |
Registration Year | 06/06/2022 |
Pending Year | 17/09/2020 |
Price Comparison
● Country: | Greece | |
● Package Size: | 56 | |
● Public Price: | 57.05 EUR | ( 5,526,775.80 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 1,0188 EUR | ( 96,876.00 LBP ) |
● Exfactory Price: | 39.47 EUR | |
● Pharmacy Price: | 41.4 EUR | ( 4010666.4 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Tablet, Film-Coated | |
● Package Size: | Box of 56 | |
● Public Price: | 3156820.42 LBP | ( 3,156,820.42 LBP ) |
● Pack size unit used: | 56 | |
● Cost/Unit: | 56371,79 LBP | ( 56,371.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File